Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Abcellera Biologics Inc (NQ: ABCL ) 2.465 -0.105 (-4.09%) Streaming Delayed Price Updated: 1:21 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Abcellera Biologics Inc < Previous 1 2 3 4 5 6 7 8 9 10 Next > AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024 September 26, 2024 From AbCellera Biologics Inc. Via Business Wire AI-Focused Drug Discovery Stocks +6% Last Week Vs. -8% Previous Week September 15, 2024 The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030 which should result in as many as 50 novel therapies being brought to market by then and generate annual... Via Talk Markets AI-Focused Drug Discovery Stocks Portfolio -8% W/e Sept 6th September 10, 2024 The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030 and should result in as many as 50 novel therapies being brought to market by then and generate annual... Via Talk Markets Our AI-Focused Drug Discovery Stocks Portfolio Down 8% In August; Down 6.7% Yesterday Alone! September 05, 2024 The August ISM manufacturing index reported on Tuesday that figures came in below consensus expectation. That raised fears about the strength of the economy, driving down our Our AI-Focused Drug... Via Talk Markets Topics Economy Exposures Economy AbCellera to Present at Upcoming Investor Conferences in September August 29, 2024 From AbCellera Biologics Inc. Via Business Wire Our AI-Focused Drug Discovery Stocks Portfolio Was Up Almost 7% Last Week August 27, 2024 The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030. Via Talk Markets This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday August 20, 2024 Via Benzinga AI-Focused Drug Discovery Stocks Portfolio Hit Hard: Down 14% MTD August 14, 2024 The AI-powered drug discovery process is expected to grow by a 30% CAGR between now and 2030 which should result in approximately 50 novel therapies and generate annual sales in excess of $50 billion... Via Talk Markets AbCellera Biologics (ABCL) Q2 2024 Earnings Call Transcript August 07, 2024 ABCL earnings call for the period ending June 30, 2024. Via The Motley Fool Topics Earnings Exposures Financial AbCellera Reports Q2 2024 Business Results August 06, 2024 From AbCellera Biologics Inc. Via Business Wire AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines July 31, 2024 From AbCellera Biologics Inc. Via Business Wire AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD July 30, 2024 The AI-powered drug discovery process is expected to grow by a CAGR of 30% by 2030. Via Talk Markets "Bubble" In AI/Semiconductor Stocks Began To Re-Inflate On Friday July 28, 2024 A week ago it was suggested that the AI/semiconductor stocks sector was oversold. The decline bottomed on Wednesday and by the close of business this past Friday the sector had rebounded nicely almost... Via Talk Markets Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio? July 21, 2024 The Baker brothers are billionaires with a successful track record in the biopharmaceutical industry. Via The Motley Fool AI-Powered Drug Discovery Stocks Portfolio Up 14% MTD; Still Down 30% YTD July 18, 2024 To capitalize on the transition to more AI-focused drug development investors need to understand the drug development process and the financial health and market potential of those companies under... Via Talk Markets Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD July 14, 2024 The 10 clinical-stage AI-focused and psychedelic compound-based drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio are UP 12.8% MTD after having gone DOWN 13.2%, on average,... Via Talk Markets 3 Biotech Stocks That Can Gain Exponentially By Leveraging AI July 02, 2024 Although fraught with risk, these biotech exposures bring enormous upside potential. Via Talk Markets AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024 June 25, 2024 From AbCellera Biologics Inc. Via Business Wire Largest Clinical-Stage BioTech Drug Stocks Declined 6% June 22, 2024 Of the 10 clinical-stage AI-focused and psychedelic compound-based small cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, only 1 advanced this week. On average they... Via Talk Markets AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th June 17, 2024 The global Via Talk Markets Down 57%, Is AbCellera Biologics a Buy on the Dip? June 13, 2024 Wall Street analysts say this drug developer can more than double your money. Via The Motley Fool AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week June 10, 2024 The global Via Talk Markets AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 May 28, 2024 From AbCellera Biologics Inc. Via Business Wire Largest Clinical-Stage BioTech Drug Stocks Declined Slightly Last Week May 27, 2024 This article highlights the performances last week and MTD of the 10 clinical-stage AI-powered and psychedelic compound-based small cap drug discovery companies along with their areas of focus in our... Via Talk Markets A $50B AI Drug Discovery Revolution Has Begun - Here Are 6 Stocks To Consider Investing In May 20, 2024 The drug development process is very expensive and time-consuming which creates a huge shortage in drug candidates and programs but the advent of AI can significantly shorten and cheapen this process... Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week May 13, 2024 Via Talk Markets 3 Stock Gems Hiding in the Nasdaq May 13, 2024 If you don’t mind taking a risk in the discount section, these undervalued Nasdaq stocks just might surprise some folks. Via InvestorPlace 5 Of 7 AI Categories Rose, Slightly,Over Past Week May 11, 2024 The 7 AI categories we track went up marginally (1.0%, on average) the second week of May, after having gone down 0.4% the previous week. Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript May 08, 2024 ABCL earnings call for the period ending March 31, 2024. Via The Motley Fool Topics Earnings Exposures Financial ABCL Stock Earnings: AbCellera Biologics Beats EPS, Misses Revenue for Q1 2024 May 07, 2024 ABCL stock results show that AbCellera Biologics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.